BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21817904)

  • 1. Validation of multiplex ligation-dependent probe amplification for confirmation of array comparative genomic hybridization.
    Jennings LJ; Yu M; Fitzpatrick C; Smith FA
    Diagn Mol Pathol; 2011 Sep; 20(3):166-74. PubMed ID: 21817904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of genomic alterations in neuroblastoma by multiplex ligation-dependent probe amplification and array comparative genomic hybridization: a comparison of results.
    Combaret V; Iacono I; Bréjon S; Schleiermacher G; Pierron G; Couturier J; Bergeron C; Blay JY
    Cancer Genet; 2012 Dec; 205(12):657-64. PubMed ID: 23265803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing a simple multiplex ligation-dependent probe amplification (MLPA) assay for rapid detection of copy number variants in the genome.
    Shen Y; Wu BL
    J Genet Genomics; 2009 Apr; 36(4):257-65. PubMed ID: 19376486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of MLPA for the detection of cryptic subtelomeric rearrangements.
    Monfort S; Orellana C; Oltra S; Roselló M; Guitart M; Martínez F
    J Lab Clin Med; 2006 Jun; 147(6):295-300. PubMed ID: 16750667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting ligated fragments on oligonucleotide microarrays: optimizing chip design, array multiplex ligation-dependent probe amplification modification, and hybridization parameters.
    Berry IR; Delaney CA; Taylor GR
    Methods Mol Biol; 2007; 381():247-65. PubMed ID: 17984523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved testing for CMT1A and HNPP using multiplex ligation-dependent probe amplification (MLPA) with rapid DNA preparations: comparison with the interphase FISH method.
    Slater H; Bruno D; Ren H; La P; Burgess T; Hills L; Nouri S; Schouten J; Choo KH
    Hum Mutat; 2004 Aug; 24(2):164-71. PubMed ID: 15241798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia.
    Coll-Mulet L; Santidrián AF; Cosialls AM; Iglesias-Serret D; de Frias M; Grau J; Menoyo A; González-Barca E; Pons G; Domingo A; Gil J
    Br J Haematol; 2008 Sep; 142(5):793-801. PubMed ID: 18564355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Utilization of MLPA to detection of genetic changes in neuroblastoma].
    Vícha A; Eckschlager T
    Klin Onkol; 2008; 21(4):149-53. PubMed ID: 19102220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent resonance energy transfer (FRET) based detection of a multiplex ligation-dependent probe amplification assay (MLPA) product.
    Ozalp VC; Nygren AO; O'Sullivan CK
    Mol Biosyst; 2008 Sep; 4(9):950-4. PubMed ID: 18704233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of array comparative genomic hybridization for genetic analysis of chorionic villus sampling from pregnancy loss in comparison to karyotyping and multiplex ligation-dependent probe amplification.
    Deshpande M; Harper J; Holloway M; Palmer R; Wang R
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):421-4. PubMed ID: 20408732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness.
    Lips EH; Laddach N; Savola SP; Vollebergh MA; Oonk AM; Imholz AL; Wessels LF; Wesseling J; Nederlof PM; Rodenhuis S
    Breast Cancer Res; 2011 Oct; 13(5):R107. PubMed ID: 22032731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification.
    Moelans CB; de Weger RA; van Diest PJ
    Breast Cancer Res Treat; 2010 Feb; 120(1):1-7. PubMed ID: 19760503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients.
    Zeng F; Ren ZR; Huang SZ; Kalf M; Mommersteeg M; Smit M; White S; Jin CL; Xu M; Zhou DW; Yan JB; Chen MJ; van Beuningen R; Huang SZ; den Dunnen J; Zeng YT; Wu Y
    Hum Mutat; 2008 Jan; 29(1):190-7. PubMed ID: 17854090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
    Fabris S; Scarciolla O; Morabito F; Cifarelli RA; Dininno C; Cutrona G; Matis S; Recchia AG; Gentile M; Ciceri G; Ferrarini M; Ciancio A; Mannarella C; Neri A; Fragasso A
    Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex ligation-dependent probe amplification (MLPA) in prenatal diagnosis-experience of a large series of rapid testing for aneuploidy of chromosomes 13, 18, 21, X, and Y.
    Gerdes T; Kirchhoff M; Lind AM; Vestergaard Larsen G; Kjaergaard S
    Prenat Diagn; 2008 Dec; 28(12):1119-25. PubMed ID: 19003800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses.
    White SJ; Vink GR; Kriek M; Wuyts W; Schouten J; Bakker B; Breuning MH; den Dunnen JT
    Hum Mutat; 2004 Jul; 24(1):86-92. PubMed ID: 15221792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex Amplifiable Probe Hybridization (MAPH) methodology as an alternative to comparative genomic hybridization (CGH).
    Kousoulidou L; Sismani C; Patsalis PC
    Methods Mol Biol; 2010; 653():47-71. PubMed ID: 20721737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas.
    Ribeiro FR; Henrique R; Hektoen M; Berg M; Jerónimo C; Teixeira MR; Lothe RA
    Mol Cancer; 2006 Sep; 5():33. PubMed ID: 16952311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of cryptic subtelomeric chromosome abnormalities and identification of anonymous chromatin using a quantitative multiplex ligation-dependent probe amplification (MLPA) assay.
    Northrop EL; Ren H; Bruno DL; McGhie JD; Coffa J; Schouten J; Choo KH; Slater HR
    Hum Mutat; 2005 Nov; 26(5):477-86. PubMed ID: 16170807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.